Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Similar articles for PubMed (Select 17768129)

1.

Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells.

Grandjenette C, Kennel A, Faure GC, Béné MC, Feugier P.

Haematologica. 2007 Sep;92(9):1279-81.

2.

Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.

Jahrsdörfer B, Wooldridge JE, Blackwell SE, Taylor CM, Griffith TS, Link BK, Weiner GJ.

J Leukoc Biol. 2005 Mar;77(3):378-87. Epub 2004 Dec 6.

3.

A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation.

Månsson A, Adner M, Höckerfelt U, Cardell LO.

Immunology. 2006 Aug;118(4):539-48. Epub 2006 Jun 16.

4.

Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.

Wolska A, Cebula-Obrzut B, Smolewski P, Robak T.

Leuk Lymphoma. 2013 Jun;54(6):1268-78. doi: 10.3109/10428194.2012.741233. Epub 2012 Nov 20.

PMID:
23078646
5.

Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation.

Rozková D, Novotná L, Pytlík R, Hochová I, Kozák T, Bartůnková J, Spísek R.

Int J Cancer. 2010 Mar 1;126(5):1132-43. doi: 10.1002/ijc.24832.

PMID:
19685493
6.

Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.

Marshall JD, Heeke DS, Gesner ML, Livingston B, Van Nest G.

J Leukoc Biol. 2007 Sep;82(3):497-508. Epub 2007 Jun 12.

7.

Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.

Liang X, Moseman EA, Farrar MA, Bachanova V, Weisdorf DJ, Blazar BR, Chen W.

Blood. 2010 Jun 17;115(24):5041-52. doi: 10.1182/blood-2009-03-213363. Epub 2010 Mar 25.

8.

Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells.

Spaner DE, Shi Y, White D, Mena J, Hammond C, Tomic J, He L, Tomai MA, Miller RL, Booth J, Radvanyi L.

Leukemia. 2006 Feb;20(2):286-95.

PMID:
16341037
9.

Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.

Schmitt A, Li L, Giannopoulos K, Greiner J, Reinhardt P, Wiesneth M, Schmitt M.

Transfusion. 2008 May;48(5):861-70. doi: 10.1111/j.1537-2995.2007.01616.x. Epub 2008 Jan 15.

PMID:
18208411
10.
11.

B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides.

Jahrsdorfer B, Mühlenhoff L, Blackwell SE, Wagner M, Poeck H, Hartmann E, Jox R, Giese T, Emmerich B, Endres S, Weiner GJ, Hartmann G.

Clin Cancer Res. 2005 Feb 15;11(4):1490-9.

12.

Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.

Arvaniti E, Ntoufa S, Papakonstantinou N, Touloumenidou T, Laoutaris N, Anagnostopoulos A, Lamnissou K, Caligaris-Cappio F, Stamatopoulos K, Ghia P, Muzio M, Belessi C.

Haematologica. 2011 Nov;96(11):1644-52. doi: 10.3324/haematol.2011.044792. Epub 2011 Jul 12.

13.

Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.

Muzio M, Scielzo C, Bertilaccio MT, Frenquelli M, Ghia P, Caligaris-Cappio F.

Br J Haematol. 2009 Feb;144(4):507-16. doi: 10.1111/j.1365-2141.2008.07475.x. Epub 2008 Nov 19.

PMID:
19036098
14.

Cultured human melanocytes express functional toll-like receptors 2-4, 7 and 9.

Yu N, Zhang S, Zuo F, Kang K, Guan M, Xiang L.

J Dermatol Sci. 2009 Nov;56(2):113-20. doi: 10.1016/j.jdermsci.2009.08.003. Epub 2009 Sep 8.

PMID:
19740627
15.

Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis.

McGettrick AF, O'Neill LA.

Br J Haematol. 2007 Oct;139(2):185-93. Review.

PMID:
17897294
16.

A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.

Assaf A, Esteves H, Curnow SJ, Browning MJ.

Cell Immunol. 2009;259(1):90-9. doi: 10.1016/j.cellimm.2009.06.003. Epub 2009 Jun 6.

PMID:
19573862
17.

Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells.

Wu CC, Castro JE, Motta M, Cottam HB, Kyburz D, Kipps TJ, Corr M, Carson DA.

Hum Gene Ther. 2003 Jun 10;14(9):849-60.

PMID:
12828856
18.

Toll-like receptors and their role in hematologic malignancies.

Wolska A, Lech-Maranda E, Robak T.

Curr Mol Med. 2009 Apr;9(3):324-35. Review.

PMID:
19355914
19.

Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agents.

Shi Y, White D, He L, Miller RL, Spaner DE.

Cancer Res. 2007 Feb 15;67(4):1823-31.

20.

[Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].

Ren T, Cai YY, Liang YJ, Jin ML, Guo ZL, Tao MF, He X.

Zhonghua Yi Xue Za Zhi. 2008 Apr 29;88(17):1168-72. Chinese.

PMID:
18844109
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk